Trigeminal neuralgia (TN) increases in prevalence with age. Although microvascular decompression (MVD) is the most effective long-term operative treatment for TN, its use in older patient populations has been debated due to its invasive nature. Recent studies have demonstrated safety of MVD in older patients; however, efficacy data are more limited. OBJECTIVE: To determine the relationship between age and pain outcomes following MVD for TN. METHODS: Subjects underwent MVD for TN at our institution between 1/1/2004 and 12/31/2013, had typical TN, and demonstrated neurovascular compression on preoperative imaging. We performed a retrospective case series study by reviewing the electronic medical records and performing phone interviews to determine long-term outcomes. We divided patients into 2 groups for analysis, under 60 and 60 yr of age and older. RESULTS: One hundred twenty-four subjects were included in the study, 82 under 60, and 42 60 yr of age and older. The average length of follow-up was 42.4 mo. Patients in the older age group had average pain score of 1.57 at most recent follow-up, while for the younger age group it was 2.18 (P = .0084). Multiple regression analysis found that older age, male gender, and preoperative medication responsiveness were significantly correlated with lower long-term pain scores, while V2 dermatome involvement was correlated with higher long-term pain scores. CONCLUSION: Patients 60 yr of age and older have significantly better long-term pain outcomes following MVD than younger patients.
T
rigeminal neuralgia (TN) is a debilitating facial pain syndrome characterized by severe episodic pain in the distribution of branches of the trigeminal nerve. TN is more common in elderly patients. 1 While first line therapy is pharmacologic treatment with medications such as carbamazepine, surgical therapy can provide long-lasting relief to patients who have medically refractory pain or whose treatment is limited by medication side effects.
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Microvascular decompression (MVD) is the most effective long-term surgical treatment for TN. [2] [3] [4] However, given the increased invasiveness of MVD compared to percutaneous treatments for TN, its use in the older patient population has been debated.
Several studies have demonstrated safety of MVD in elderly patients similar to that in younger patients. [5] [6] [7] [8] [9] [10] [11] Others have suggested a higher rate of complications in elderly patients. [12] [13] [14] Data on efficacy of MVD in this patient group is more limited, with most studies focusing on safety but suggesting similar efficacy. 5, [7] [8] [9] [10] [11] There is evidence that younger patients may have worse outcomes following MVD. 15 Several factors have been identified that correlate with favorable outcome following MVD, including presence of arterial neurovascular compression, 2 typical (type I) TN (characterized by episodic lancinating pain), 16, 17 shorter duration of preoperative symptoms, 18, 19 and presence of preoperative trigger points. 16 The goal of our study was to determine the relationship between age and efficacy of MVD for TN in patients with typical TN and demonstrated neurovascular compression on preoperative imaging.
METHODS

Subjects
Subjects were recruited from a group of patients who underwent MVD for TN with a single surgeon at our institution between January 1, 2004 and December 31, 2014. Patients were eligible to participate in the study if they were at least 18 yr of age at the time of their surgery, had typical (type I) TN, and had evidence of neurovascular compression (arterial and/or venous) on preoperative imaging. Three hundred nineteen patients were screened for eligibility. Fifty-three were excluded because they did not have evidence of neurovascular compression on preoperative imaging, while 37 had atypical TN. Twenty-nine had both atypical TN and no evidence of neurovascular compression on preoperative imaging. Sixty-five were excluded because they had no follow-up information available. One hundred thirty-five patients met eligibility criteria. Patients were sent a letter describing the study and providing a return postcard allowing them to opt out of the study. The study was approved by the Institutional Review Board. As approved by the Institutional Review Board, subjects provided verbal informed consent at the time of the phone interview. Eleven patients declined to participate in the study. One hundred twenty-four subjects were ultimately included in the study. This manuscript follows the STROBE reporting guideline.
The initial portion of the study involved a retrospective review of medical records to gather demographic and clinical information. In the second portion of the study, patients who did not opt out were contacted via telephone and if they gave verbal consent a telephone survey was performed to gather long-term follow-up data. We used the Barrow Neurologic Institute (BNI) Pain Score 20 to quantify TN symptoms (Table 1) . Outcome measures were final BNI pain score and change in BNI pain score. We also categorized outcomes into good pain control (BNI score I-II) and poor pain control (BNI score III-V) for analysis. We additionally recorded variables previously reported to be associated with outcome following MVD, including type of vascular compression seen at time of surgery (arterial versus venous), duration of preoperative symptoms, previous procedures, presence of preoperative trigger points, preoperative medication responsiveness, and pain distribution. 
Analysis
Statistical analysis was performed using MATLAB (MathWorks, Natick, Massachusetts). Patients were divided into 2 age groups for analysis, a younger age group defined as less than 60 yr of age at time of surgery and an older age group defined as 60 yr of age and older. Subjects with missing information were excluded from the relevant portion of the analysis. Continuous variables were compared between the 2 age groups using the Wilcoxon Rank Sum Test and categorical variables were compared using Fisher's exact test. We reviewed the literature to determine previously identified factors related to outcome. These included disease duration, having undergone pervious procedures for TN, presence of arterial compression, preoperative trigger points, preoperative medication responsiveness, and dermatomes involved. We performed univariate regression analysis to identify the relationship between clinical predictive factors and the 2 outcomes. We additionally performed stepwise regression in order to determine which variables to include in multiple regression analysis. The variables identified on stepwise regression analysis were the same as those identified as significant on univariate regression analysis. We additionally included intraoperative arterial compression and previous TN procedures in multivariate analysis as we had identified them from our literature review as two of the most important variables likely to affect outcome. As a sensitivity analysis, we performed the same multiple regression analysis using the categories of good and poor pain control as outcomes. We used a P value of <.05 to determine significance.
RESULTS
Subjects
There were 124 patients included in our study. Eighty-two fell into the under 60 age group and 42 were 60 and over. The mean age of all patients in the study was 52.9 (median 53), 45.6 in the younger group, and 70.0 in the older group (median 48 and 67 respectively, P < .0001, Wilcoxon rank sum test). Of the patients who were excluded because we were unable to obtain follow-up information, 50 fell into the under 60 age group and 15 fell into the 60 and over age group (P = .14, Fisher's exact test). This suggests that differences between the groups are not related to differences in ability to obtain follow-up between the 2 age groups. Fifty-six percent of participants were women; 52% were women in the older group and 59% were women in the younger group (P = .57, Fisher's exact test). The average follow-up length of all study subjects was 42.4 mo; 45.0 in the younger group and 37.3 in the older group (P = .22, Wilcoxon rank sum test). In the older patient group, 6 patients had previously undergone radiofrequency ablation, 3 had undergone previous gamma knife, and none had previously undergone MVD. In the younger patient group, 3 had previously undergone contralateral MVD, 1 had previously undergone ipsilateral MVD for hemifacial spasm, 2 had previously undergone ipsilateral MVD for TN, 1 had undergone previous radiofrequency ablation, and 5 had undergone gamma knife. There was no difference in the proportion of patients who had undergone previous procedures between the 2 groups (P = .45, Fisher's exact test). Demographic and clinical variables for the 2 patient groups are shown in Table 2 . Older patients had significantly longer disease duration (7.4 vs 4.4 yr, P = .0016 Wilcoxon rank sum test) and were more likely to have arterial neurovascular compression at the time of surgery (97.6 vs 76.8%, P = .0018, Fisher's exact test). None of the other demographic and clinical predictive variables were significant between the 2 groups.
Complications occurred in 22.0% of younger patients and 26.2% of older patients. There was no significant difference in complication rates between the 2 groups (P = .66, Fisher's exact test). The types and number of complications experienced by patients in each group are shown in Table 3 . The complication rate we observed in older patients was similar to that of other single institution studies examining the safety of MVD for TN in older patients (Table, Supplemental Digital Content 1).
Outcome
Patients in the older age group had a greater improvement in pain score following surgery than patients in the younger group. In the 60 and older group, the mean improvement in pain score was 2.64 at most recent follow-up, while in the under 60 group it was 2.15 (P = .035, Wilcoxon rank sum test, Figure 1A ). While there was no difference in preoperative pain scores, the older group also had significantly lower pain scores at most recent follow up (1.57 for 60 and over, 2.18 for under 60 age group, P = .0084 Wilcoxon rank sum test, Figure 1B) . When patients were divided into good pain control and poor pain control outcomes groups, with good pain control defined as BNI pain score I or II and poor pain control defined as BNI pain score III-V, 83.3% of the older patient group had good pain control at most recent follow-up, while 57.3% of the younger patient group had good pain control at most recent follow-up (P = .047, Fishers exact test, Figure 1C) .
We performed univariate analysis to investigate the relationship between clinical and demographic factors and final pain score. Older age was significantly associated with lower final pain score (P = .0043), as was male gender (P = .016) and preoperative medication responsiveness (P = .0053). Involvement of V2 dermatome was associated with higher final pain score (P = .043). None of the other variables were significantly associated with outcome.
We additionally performed multiple regression analysis using the variables found to be significantly associated with outcome on stepwise regression analysis in addition to the presence of intraoperative arterial compression and previous TN procedures, factors that we identified as potentially being particularly important in contributing to outcome, to examine for interaction. Age, gender, preoperative medication responsiveness, and involvement of V2 remained significant on multiple regression analysis, while intraoperative arterial compression and having undergone previous procedures for TN did not significantly predict outcome (Table 4) . We additionally performed multivariate regression analysis using the same predictor variables with good pain control (final BNI pain score I-II) versus poor pain control (final BNI pain score III-V) as the outcomes, and found that age, preoperative medication responsiveness, and V2 dermatome involvement remained significant predictors of response, while gender was no longer significant, and intraoperative arterial compression and previous TN procedures remained nonsignificant (Table, Supplemental Digital Content 2).
DISCUSSION
Our results suggest that patients 60 and older have better pain outcomes following MVD than do younger patients. Additional factors associated with good pain outcome included male gender and preoperative medication responsiveness, while V2 pain distribution was associated with worse pain outcomes. Few studies have focused on the relationship between MVD efficacy and age. A systematic review reported that while older and younger patients have similar initial success rates following MVD, older patients have lower recurrence rates. 12 Interestingly, a study examining the outcome of young adults (18-25) with TN following MVD found that this younger age group had poor pain outcomes. 15 In this study, all patients were found to have venous compression at the time of surgery. 15 We report that patients 60 and older have significantly better long-term pain control than patients under 60. In our cohort, 57.3% of younger patients had good pain control at most recent follow-up, a proportion which is relatively low compared to the literature. There are several possible reasons for this. First, good outcome is defined in many different ways in the literature. Our definition of BNI score I or II is relatively strict, excluding patients with BNI score III who have some pain that is adequately controlled with medications. The average BNI score at most recent followup in this group was 2.18, indicating relatively good pain control. Additionally, the average age in the younger group was relatively young, at 45.6. Previous studies have suggested worse outcomes in young patients, 15 perhaps contributing to this finding. Within the younger age group, there was a trend towards improving outcomes with increasing age (Figure, Supplemental Digital Content 3) , suggesting that the worse outcomes in the younger group may be related to its younger average age.
TN is more common in older patients. 1 TN may be related to arteriosclerosis, with the development of arteriosclerosis gradually changing vessel shape and conformation, potentially leading to neurovascular compression. 21 This association may explain the relationship between age and TN incidence, given the increasing prevalence of arteriosclerosis with age. 21 This relationship may also contribute to the increased incidence of arterial neurovascular compression seen in older TN patients, both in our study and in several previous reports. One study reported that patients who did not have neurovascular compression identified at the time of surgery were younger. 22 Another report found that patients under 70 were significantly more likely to have venous compression noted intraoperatively than older patients. 5 The presence and degree of arterial compression have been linked to outcome following MVD, relationship between MVD outcome and age. In our study, we found that older patients had a higher rate of arterial neurovascular compression observed at the time of surgery. However, we did not find a relationship between arterial compression and outcome following MVD on univariate or multivariate analysis, suggesting that the greater incidence of arterial compression at the time of surgery does not explain the better outcome in older patients in our study. Our inclusion criteria included the presence of vascular compression (arterial or venous) on preoperative imaging; therefore, all patients had either arterial and/or venous neurovascular compression, which may help to explain the lack of relationship between arterial compression and outcome seen in our study.
A relationship between shorter duration of symptoms and better pain outcomes following MVD has been reported, with 1 study finding that older age at symptom onset was associated with shorter disease duration prior to surgery. 24 However, in our study older patients had significantly longer duration of symptoms prior to surgery. Additionally, we did not find a relationship between symptom duration and pain outcome. Therefore, symptom duration is unlikely to explain the improved pain outcomes of older patients seen in our study.
The improved outcomes of older patients may be partially explained by anatomic and operative considerations. Cerebellar atrophy increases with age, facilitating cerebellopontine angle exposure. Some authors have found operative duration to be shorter in older patients for this reason. 5, 10 Similarly, increased exposure may improve ability to fully inspect and decompress the trigeminal nerve. While contact between a vessel and the trigeminal nerve can be seen in asymptomatic patients, greater degree of neurovascular compression including nerve distortion and displacement is associated with symptomatic TN. 25 Increasing age is also associated with greater neurovascular compression. 25 TN without neurovascular compression has earlier age of onset than TN with neurovascular compression, suggesting that there may be different underlying pathologies in older and younger patients. 26 While our study included only patients with neurovascular compression seen on preoperative MRI, we did not measure the degree of neurovascular compression, and it is possible that this differed between the 2 groups. Greater degree of nerve atrophy both seen intraoperatively 23 and on preoperative MRI 27 is correlated with better pain outcomes following MVD. Therefore, it is possible that the underlying etiology of TN in older patients is more amenable to treatment with MVD.
Several smaller studies have examined the relationship between age and complications following MVD and have concluded that elderly patients have similar morbidity to younger patients. [5] [6] [7] [8] [9] [10] [11] However, a systematic review found higher rates of death, stroke, and thromboembolic events following MVD in elderly patients with no difference in rates of meningitis, cranial nerve deficits, or cerebrospinal fluid leak. 12 A large study reporting on outcomes from the Nationwide Inpatient Sample, a national hospital discharge database, found that the rate of death and discharge disposition to facility other than home following MVD increased with increasing age, although rates of other complications were not affected by age. 13 Additionally, surgeon and hospital MVD volume are correlated with discharge disposition, and this effect increases with increasing patient age. 13 Another study using the Nationwide Inpatient Sample found that increasing age was correlated with increasing in hospital mortality following MVD. 14 This study also found that age correlated with incidence of cardiac, pulmonary, thromboembolic, and cerebrovascular but not central nervous system infection or wound complications. 14 There was no significant difference in overall complication rates between the 2 age groups in our cohort; however, it is likely that with a larger sample size a small increase in morbidity and mortality may be seen. Additionally, it is important to note that our patients, and in particular the older group of patients, were not offered MVD if they had significant medical comorbidities making them high-risk operative candidates, a practice that likely affects complication rates. Overall, in large patient groups there is a small but a significant relationship between age and morbidity and mortality following MVD (Table, Supplemental Digital Content 2), likely related to the higher incidence of preoperative systemic comorbidities in the older patient population. The safety profile of MVD in appropriately medically selected elderly patients remains acceptable given the severely debilitating nature of TN; however, the relationship between age and morbidity and mortality is important to consider when selecting operative modality in older patients. Our finding of better long-term pain outcomes in older patients adds additional weight to the risk benefit analysis in this patient group.
We additionally found that women had worse outcomes than men, a finding that has been previously reported. 2, 24 One study found that a greater proportion of women had a small unspecified artery or vein seen operatively as the compressive vessel. 2 Another study reported that men are more likely to have significant nerve root distortion. 24 Different underlying pathophysiology may contribute to gender differences in outcomes.
Limitations
There are several limitations to our study, including its small sample size and retrospective nature. Because of the retrospective nature, there was a relatively high number of patients whom we had to exclude because we were unable to obtain follow-up information. Because the study was retrospective and observational, we did not control which patients were referred for MVD versus other procedures. It is likely that a greater proportion of elderly patients underwent less invasive procedures; however, by using evidence of neurovascular compression on preoperative imaging and typical TN, 2 of the best characterized predictors of response following MVD, as inclusion criteria, we hoped to minimize selection bias. While our study design did not allow us to evaluate TN symptoms over time, a strength of our study is the relatively long follow-up duration. We feel that this study remains an important addition to the limited existing literature examining the relationship between age and outcome following MVD.
CONCLUSION
In our study population patients age 60 and older had better long-term pain outcomes following MVD than did patients under age 60. Additional factors associated with better outcome included male gender and preoperative medication responsiveness. V2 pain distribution was associated with worse outcome. We suggest that MVD should not be excluded as a treatment option in older typical TN patients who are medically appropriate operative candidates.
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COMMENTS
T he authors of this clinical series make a strong argument about consideration of microvascular decompression (MVD) as a primary treatment modality in older patients with trigeminal neuralgia (TN). Their data indicates that MVD was not only as safe and effective as it is in younger TN patients (something that has been repeatedly suggested by others in the past), but that long-term outcomes were better among older TN patients compared to both younger patients and the overall cohort. The reason for this finding remains unclear -and the authors' hypothesis about more severe vascular compression in patients of advanced age group may indeed be a plausible explanation.
I would think that there are 3 real reasons for better outcomes in older patients. First of all, the higher degree of brain atrophy in older patients facilitates better visualization of neurovascular situation in the cerebellopontine angle, usually eliminating need in any additional retraction. This, at least theoretically, should result in more complete inspection of the trigeminal nerve root and perhaps in more thorough decompression of the nerve during MVD. Secondly, the same degree of atrophy may result in better separation of the nerve roots and arteries after the decompression thereby reducing the chance of either residual or recurrent compression after the initial intervention. Finally, the higher surgical risks associated with cranial interventions in older patients put additional pressure on surgical teams in selecting appropriate TN cases and the threshold for offering MVD in an older TN patient is probably higher than in otherwise healthy young person with TN. This means that any case that may be somewhat atypical and therefore less responsive to MVD would probably be screened out in preparation for MVD in the older patients group. As the authors mentioned in their paper, it is conceivable that one pays more attention to preoperative radiographic findings in older TN patients and offers MVD only to those who have clear-cut vascular compression -something that may be less relevant in a younger age group where neurovascular contact may be misinterpreted for neurovascular conflict.
Similarly to the authors' experience, we did not find association between advanced age and worse MVD outcomes in a recent analysis of a large national database, 1 but at the same time, it is important to keep in mind the data from an earlier publication that analyzed thousands of TN patients treated with MVD and found highly statistically significant increases in in-hospital mortality among patients age 65 and older and 75 and older (5-and 9-fold, respectively) compared to those younger than 65. 2 The rates of complications and duration of hospital stay were higher in older patients and the likelihood of discharge home was lower. 2 I completely agree with the authors' conclusion that "MVD should not be excluded as a treatment option in older typical TN patients who are medically appropriate operative candidates," but want to encourage the readers to analyze their own MVD series and determine if their clinical experience with possibly higher rates of mortality and complications in older patient cohort justifies performance of cranial surgery in situations where multiple treatment options are available.
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